Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Army
Healthtrust
Cerilliant
Federal Trade Commission
Cipla
Medtronic
US Department of Justice
UBS

Generated: April 23, 2018

DrugPatentWatch Database Preview

LORFAN Drug Profile

« Back to Dashboard

Which patents cover Lorfan, and what generic alternatives are available?

Lorfan is a drug marketed by Roche and is included in one NDA.

The generic ingredient in LORFAN is levallorphan tartrate. Additional details are available on the levallorphan tartrate profile page.
Drug patent expirations by year for LORFAN
Medical Subject Heading (MeSH) Categories for LORFAN
Synonyms for LORFAN
(-)-3-Hydroxy-N-allylmorphinan
(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0;{1,10}.0;{2,7}]heptadeca-2(7),3,5-trien-4-ol
(1R,9R,10R)-17-(PROP-2-EN-1-YL)-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2(7),3,5-TRIEN-4-OL
(levallorphan)17-allyl-(1R,9R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol
152-02-3
17-allyl-(1R,9R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol( Levallorphan)
17-allyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (Levallorphan)
17-Allylmorphinan-3-ol
17-prop-2-en-1-ylmorphinan-3-ol
353613BU4U
BDBM50326673
C07069
CAS-152-02-3
CHEBI:6431
CHEMBL1254682
CTK5J4760
D04QWE
DB00504
DSSTox_CID_3205
DSSTox_GSID_23205
DSSTox_RID_76925
DTXSID9023205
EINECS 205-799-1
GTPL7209
HSDB 2148
L-N-Allyl-3-hydroxymorphinan
Levallofano
Levallofano [DCIT]
levallorphan
Levallorphan [INN:BAN]
Levallorphane
Levallorphane [INN-French]
Levallorphanum
Levallorphanum [INN-Latin]
Levalorfano
Levalorfano [INN-Spanish]
Levo-3-hydroxy-N-allyl morphinan
LS-91860
Morphinan-3-ol, 17-(2-propenyl)-
Morphinan-3-ol, 17-allyl-
Morphinan-3-ol, 17-allyl-, (-)-
Morphinan, 17-allyl-3-hydroxy-
N-Allyl-3-hydroxymorphinan
Naloxiphan
NCGC00162247-02
NCGC00162247-06
PL005026
Ro-1-7700
SCHEMBL34060
Tox21_112005
Tox21_112005_1
UNII-353613BU4U
ZINC3875992

US Patents and Regulatory Information for LORFAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche LORFAN levallorphan tartrate INJECTABLE;INJECTION 010423-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Deloitte
Moodys
QuintilesIMS
US Army
Daiichi Sankyo
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.